Outcomes following Stereotactic Body Radiation Therapy for Patients with Child-Pugh B or C Hepatocellular Carcinoma

被引:0
|
作者
Juloori, A. [1 ]
Woody, N. M. [1 ]
Menon, K. V. N. [2 ]
Romero-Marrero, C. [2 ]
Kim, A. [2 ]
Varley, M. [3 ]
Qi, P. [1 ]
Miller, C. [2 ]
Aucejo, F. [2 ]
Stephans, K. L. [1 ]
机构
[1] Cleveland Clin, Taussig Canc Inst, Dept Radiat Oncol, Cleveland, OH 44106 USA
[2] Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA
[3] Case Western Reserve Sch Med, Cleveland, OH USA
关键词
D O I
10.1016/j.ijrobp.2018.07.480
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
SU_14_2135
引用
收藏
页码:E56 / E57
页数:2
相关论文
共 50 条
  • [31] Atezolizumab plus bevacizumab in patients with child-Pugh B advanced hepatocellular carcinoma
    Cheon, Jaekyung
    Kim, Hyeyeong
    Kim, Han Sang
    Kim, Chang Gon
    Kim, Ilhwan
    Kang, Beodeul
    Kim, Chan
    Jung, Sanghoon
    Ha, Yeonjung
    Chon, Hong Jae
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [32] Evaluation of liver toxicity using Child-Pugh, MELD, and MELD-Na following stereotactic body radiation therapy (SBRT) of hepatocellular carcinomas.
    Lu, Louis
    ElAlfy, Eman
    Wahl, Daniel
    Stenmark, Matthew H.
    Lawrence, Theodore Steven
    Feng, Mary Uan-Sian
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [33] Comparison of nivolumab and sorafenib for first systemic therapy in patients with hepatocellular carcinoma and Child-Pugh B cirrhosis
    Chapin, William J.
    Hwang, Wei-Ting
    Karasic, Thomas B.
    McCarthy, Anne Marie
    Kaplan, David E.
    CANCER MEDICINE, 2023, 12 (01): : 189 - 199
  • [34] Outcomes of SBRT for HCC in Patients with Child-Pugh B and C Cirrhosis
    Lee, P.
    Sioshansi, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S136 - S136
  • [35] Outcomes of stereotactic body radiation therapy for primary hepatocellular carcinoma
    Takayesu, J. S.
    Burkeen, J.
    Simpson, D.
    Hattangadi-Gluth, J.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2017, 65 : S240 - S240
  • [36] Selection Criteria for Hepatectomy in Patients with Hepatocellular Carcinoma Classified as Child-Pugh Class B
    Kuroda, Shintaro
    Tashiro, Hirotaka
    Kobayashi, Tsuyoshi
    Oshita, Akihiko
    Amano, Hironobu
    Ohdan, Hideki
    WORLD JOURNAL OF SURGERY, 2011, 35 (04) : 834 - 841
  • [37] Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma and Child-Pugh A or B cirrhosis
    Federico, Alessandro
    Orditura, Michele
    Cotticelli, Gaetano
    De Sio, Ilario
    Romano, Marco
    Gravina, Antonietta Gerarda
    Dallio, Marcello
    Fabozzi, Alessio
    Ciardiello, Fortunato
    Loguercio, Carmela
    De Vita, Ferdinando
    ONCOLOGY LETTERS, 2015, 9 (04) : 1628 - 1632
  • [38] Survival and tolerance to sorafenib in Child-Pugh B patients with hepatocellular carcinoma: a prospective study
    Guedes Leal, Cassia Regina
    Magalhaes, Cristiane
    Barbosa, Daniel
    Aquino, Diogo
    Carvalho, Bernardo
    Balbi, Elizabeth
    Pacheco, Lucio
    Perez, Renata
    Pinto, Paulo de Tarso
    Setubal, Sergio
    INVESTIGATIONAL NEW DRUGS, 2018, 36 (05) : 911 - 918
  • [39] Transarterial Chemoembolization for Patients with Unresectable Hepatocellular Carcinoma with Child-Pugh B7
    Jiang, Jian-Qiang
    Zhong, Bin-Yan
    Wang, Wei -Dong
    Wang, Qi
    Ding, Wen-Bin
    Ni, Cai-Fang
    Zhu, Xiao-Li
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2023, 10 : 1629 - 1638
  • [40] Regorafenib in patients with advanced Child-Pugh B hepatocellular carcinoma: A multicentre retrospective study
    Kim, Hyung-Don
    Bang, Yeonghak
    Lee, Myung Ah
    Kim, Jin Won
    Kim, Jee Hyun
    Chon, Hong Jae
    Kang, Beodeul
    Kang, Myoung Joo
    Kim, Ilhwan
    Cheon, Jaekyung
    Hwang, Jun-Eul
    Kang, Jung Hun
    Byeon, Seonggyu
    Hong, Jung Yong
    Ryoo, Baek-Yeol
    Lim, Ho Yeong
    Yoo, Changhoon
    LIVER INTERNATIONAL, 2020, 40 (10) : 2544 - 2552